Back to results
US 7,018,639 B1Granted
Vaccine antigens of Moraxella
AssigneesCommonwealth Scientific and Industrial Research Organisation, The University of Melbourne
InventorsJacinta Farn, Richard Strugnell, Jan Tennent
Life of this patent
Estimating the term…
Abstract
The present invention relates to antigens of Moraxella, in particular, Moraxella bovis, nucleic acid sequences encoding these antigens and formulations for use in raising an immune response against Moraxella.
Claims3
An isolated polypeptide comprising the amino acid sequence as set out in SEQ ID NO:
- 5.
A composition for use in raising an immune response in an animal, the composition comprising a substantially purified polypeptide having the amino acid sequence as set out in SEQ ID NO:
- 5 and optionally a carrier and/or adjuvant.
Dependencies are inferred from the claim text.